• Home
  • Dubravka Cvejić

Dubravka Cvejić

Organization group: Department for Endocrinology and Radioimmunology 

Academic Degree: Molecular Biologist and Physiologist, PhD in Biological Sciences

Current Position: Pricipal Research Fellow, QMS Representative

Leading positions: QMS Representative; Leader of the national project: “Molecular characterization of the thyroid gland tumors: biological and clinical aspects” (Project No. 173050, Ministry of Education, Science and Technological Development, Republic of Serbia, 2011-2019 ).

Education: Graduated molecular biologist and physiologist, Faculty of Biology, University of Belgrade, Serbia (1980). M. Sc Thesis (1985) and PhD Thesis (1995) in Biological Sciences at Faculty of Biology, University of Begrade, Serbia.

Research Field:

Organizes and participates work of INEP scientific group involved in basic research of  the thyroid gland with the focus on molecular pathogenesis of thyroid gland tumors.

Membership in International and National Societies:

Member of the Serbian Biological Society
Member of the Serbian Thyroid Society
Member of the Serbian Biochemical Society
Member of the European Thyroid Association (ETA)

Other responsibilities:

Member of  INEP Management Board
Deputy Manager of the Quality Control System, quality management according to international standards ISO 9001:2015, ISO 13485:2016, ISO 17025:2017.

Bibliography (2015-2018):

ORCID ID: http://orcid.org/0000-0001-6771-9683

Denčić Išić T, Bartolome A, Šelemetjev S, Đorić I, Tatić S, Živaljević V, Cvejić D. High expression and localization of β-catenin and epidermal growth factor receptor identify high risk papillary thyroid carcinoma patients. Exp Mol Pathol. 2018; 105:181-189.

Šelemetjev S, Bartolome A,   Išić Denčić T٭, Đorić I,  Paunović I,  Tatić S, Cvejić D.٭ Overexpression of EGF receptor and its downstream effector, focal adhesion kinase (FAK), correlates with papillary thyroid carcinoma progression. Int J Exp Pathol, 2018; 99:87-94

Janković J, Tatić S, Božić V, Živaljević V, Cvejić D, Paskaš S. Inverse expression of caveolin-1 and EGFR in thyroid cancer patients. Hum Pathol. 2017; 61:164-172.

Šelemetjev S, Ðoric I, Paunovic I, Tatic S, Cvejic D. Coexpressed High Levels of VEGF-C and Active MMP-9 Are Associated With Lymphatic Spreading and Local Invasiveness of Papillary Thyroid Carcinoma. Am J Clin Pathol. 2016; 146(5):594-602.

Bartolome A, Boskovic S, Paunovic I, Bozic V, Cvejic D. Stomatin-like protein 2 overexpression in papillary thyroid carcinoma is significantly associated with high-risk clinicopathological parameters and BRAFV600E mutation. APMIS. 2016; 124(4):271-277.

Dunđerović D, Lipkovski JM, Boričic I, Soldatović I, Božic V, Cvejić D, Tatić S Defining the value of CD56, CK19, Galectin 3 and HBME-1 in diagnosis of follicular cell derived lesions of thyroid with systematic review of literature. Diagn Pathol. 2015; 10:196-218.

Paskaš S, Janković J, Živaljević V, Tatić S, Božić V, Nikolić A, Radojković D, Savin S, Cvejić D. Malignant risk stratification of thyroid FNA specimens with indeterminate cytology based on molecular testing. Cancer Cytopathol. 2015; 123(8):471-479.

Dencic TM, Savin SB, Selemetjev SA, Paskas SD, Zivaljevic VR, Bozic VD, Cvejic D. Strong expression of HBME-1 associates with high-risk clinicopathological factors of papillary thyroid carcinoma. Pathol Oncol Res. 2015 ;21(3):735-742.